Abstract Leukotriene (LT) B4 is an important pro-inflammatory autocoid. In order to investigate the potential role of this eicosanoid in renal inflammation, in this study we determined the capability of glomeruli to synthesize this mediator. Glomeruli were able to synthesize LTB4 when provided with exogenous substrate in a dose-dependent fashion in the presence of ionophore A23187. Ionophore, although by itself a weak agonist for LTB4 formation, was required for LTB4 production from exogenous arachidonate. The identity of LTB4 was confirmed by specific radioimmunoassay, high pressure liquid chromatography, and gas chromatography/mass spectrometry. The synthesis of LTB4 was inhibited by BW755C (a lipoxygenase/cyclooxygenase inhibitor) but not indomethacin. Essential fatty acid (EFA) deficiency, obtained by the deprivation of (n-6) fatty acids, is known to exert a protective effect in renal inflammatory states. This dietary manipulation markedly attenuated the ability of glomeruli to synthesize LTB4. In contrast, the synthesis of cyclooxygenase products from exogenous arachidonate was increased by EFA deficiency. Because EFA deficiency has been shown to deplete glomeruli of resident mesangial macrophages, it was hypothesized that this effect accounted for the diminished LTB4 synthesis. To test this hypothesis, glomeruli were depleted of macrophages using x-irradiation. Glomeruli from these animals exhibited a marked decrease in LTB4 synthesis. Glomerular synthesis of cyclooxygenase products was unaffected by irradiation. In sum, glomeruli have the capability to synthesize LTB4, and this capacity is correlated with the presence of glomerular macrophages. EFA deficiency attenuates the ability of glomeruli to synthesize LTB4 by depleting them of macrophages.
Introduction Leukotriene (LT) B4 is an important pro-inflammatory mediator. This autocoid has been shown to induce leukocyte chemotaxis (1) , to cause leukocyte adherence to endothelial cells (2) , to activate and aggregate leukocytes (3) , and to cause vascular changes in synergy with prostaglandin E2 (4) . The potential role of LTB4 in inflammation is underscored by studies which show that dietary polyunsaturated fatty acid modulation exerts an anti-inflammatory effect (5) (6) (7) . Both essential fatty acid (EFA)' deficiency and (n-3) fatty acid enrichment have been shown to inhibit LTB generation by leukocytes. In the former case, 20:3(n-9), the fatty acid that uniquely accumulates in the deficiency state (8) , is metabolized to LTA3 (9) . This reactive intermediate binds to LTA hydrolase and prevents the synthesis of LTB of either the 3 or 4 series, that is, from either 20:3(n-9) or arachidonate (10) . A similar mechanism is operative in the latter case. 20:5(n-3), the fatty acid that prominently accumulates with dietary (n-3) fatty acid enrichment, is metabolized to LTA5, which is a relatively poor substrate and an inhibitor of LTA hydrolase (1 1).
Renal eicosanoid metabolism is enhanced in a number of renal pathologic states such as glomerulonephritis (12) , adriamycin-induced nephrosis (13) , acute renal failure (14) , and hydronephrosis (15) . Additionally, this metabolic alteration appears to have pathophysiologic significance in these conditions (12) (13) (14) (15) . In order to assess the potential role of LTB4 in renal inflammation, the capability of glomeruli to synthesize this eicosanoid was assessed. This study establishes that glomeruli are indeed able to synthesize LTB4, and that EFA deficiency inhibits the generation of this eicosanoid. The mechanism by which EFA deficiency exerts its inhibitory effect, however, appears to be different than the aforementioned mechanism operative in isolated leukocytes in vitro, and suggests a unique cellular source for this mediator.
Methods
Reagents and materials. Weanling Lewis rats were obtained from Charles River Breeding Laboratories, Inc. (Wilmington, MA) and fed either a standard lab diet or a fat-free diet purchased from Purina Test Diets (Richmond, IN) for at least 8 wk. The fatty acid analysis ofthese diets has been previously published (16) . Arachidonic acid, ionophore A23 187, and DNAase type I were obtained from Sigma Chemical Co. (St. Louis, MO). Prostaglandin (PG) E2 and thromboxane (Tx) B2, degree of deficiency. 20:3(n-9)/arachidonate ratios ranged from 2 to 4, exceeding by far the minimum criterion of EFA deficiency (i.e., ratio > 0.4 [8] ).
Animals were x-irradiated to deplete glomeruli of macrophages as described (18) . Briefly, anesthetized animals were exposed to 1,315 rad of x-irradiation spread over 10 min. After 4 d the animals were leukopenic (< 90% depletion of peripheral leukocyte count) and were subsequently used in the experiments below.
Glomerular isolation, incubations, and labeling. Glomeruli were isolated from saline-perfused kidneys using a sieving protocol detailed previously (17) . Preparations were typically > 90% pure. No difference in purity was observed between preparations from normal or EFA-deficient animals. Because of previous findings that collagenase/DNAase treatment of glomeruli was necessary to preserve glomerular viability and response to agonists (17) , glomeruli were treated with 20 U/ml of collagenase type II and 0.01 mg/ml DNAase for 20 min at room temperature before use. They were then washed several times with cold oxygenated Kreb's-Henseleit buffer.
Glomerular incubations were then carried out as previously described (17) (Table I ). Both drugs inhibited the simultaneous production of TxB2 (Table I) . The synthesis of LTB4 from arachidonate was dose dependent but required higher concentrations of substrate to obtain maximal production relative to cyclooxygenase metabolites (Table II) . The synthesis of LTB4 also required the presence of ionophore A23 187 (Figure 2 ). Exogenous arachidonate alone was not efficiently converted to LTB4. Ionophore alone was a weak agonist for LTB4 production. Only with the combination of ionophore and exogenous arachidonate was substantial LTB4 generated. In contrast, arachidonate was converted to PGE2 efficiently in the presence or absence of ionophore.
Production of LTB4 was apparently from an endogenous cell in the glomerulus rather than a blood element in that glomeruli were perfused free of blood before use. As has been shown before, perfused glomeruli are virtually devoid of blood cell contamination: < 1% of dissociated glomerular cells are red blood cells (20) . The potential contribution ofblood-borne cells to glomerular LTB4 synthesis, however, was more directly tested by comparing the LTB4 production by perfused glomeruli to that of unperfused glomeruli. Unperfused glomeruli synthesized identical quantities of LTB4 to perfused glomeruli: 33 and 25 fmol/103 glomeruli at 10 peM arachidonate, respectively, and 170 and 168 fmol/103 glomeruli at 30 ,uM arachidonate, respectively. Thus, blood-borne cells contributed little to the observed LTB4 production.
The issue of whether perfused glomeruli contained any contaminating leukocytes (e.g., polymorphonuclear neutrophils or lymphocytes) was also addressed by labeling dissociated glomerular cells for the leukocyte common antigen. In cell preparations from normal glomeruli 4.4% of the cells stained positively for the leukocyte common antigen. Of the Effects of (n-6) fatty acid deprivation on glomerular LTB4 synthesis. Since EFA deficiency exerts an anti-inflammatory effect in renal inflammation (5) , the effects of the deficiency state on glomerular LTB4 synthesis were examined. EFA deficiency inhibited the production of LTB4 by 50-80% (Table  III) . This effect contrasted with the effects of EFA deficiency on cyclooxygenase metabolites. EFA-deficient glomeruli synthesized greater amounts of TxB2 and PGE2 (Table III) (17) , and macrophages are known to have the capability to synthesize this eicosanoid (19) . In order to test this assumption, glomeruli were depleted of macrophages using whole-body irradiation. This procedure leads to a profound depletion of macrophages from the glomerulus (Fig. 3) . Glomeruli from irradiated animals exhibited a 50-80% decrease in LTB4 synthesis from exogenous arachidonate (Table IV) . In contrast, the synthesis of PGE2 and TxB2 from arachidonate was relatively unaffected by irradiation. These data served to support the hypothesis that the mesangial macrophage is the major source of glomerular LTB4, and that EFA deficiency inhibited glomerular LTB4 synthesis by depleting the glomerulus of this cell.
Discussion
Glomeruli have long been known to synthesize a host of eicosanoids, including the prostaglandins and hydroxyeicosatetraenoic acids (21, 22) . The various component cells of the glomerulus (e.g., mesangial cells and epithelial cells) also have been cultured in vitro and were found to synthesize these metabolites to greater or lesser degrees (23) . Only recently, however, has it been appreciated that the glomerulus contains a resident mesangial macrophage (20 The requirement for ionophore in glomerular LTB4 synthesis from exogenous substrate is similar to a previously described phenomenon observed in macrophages. Macrophages synthesize only cyclooxygenase products in response to soluble stimuli, such as phorbol myristate acetate, and inefficiently convert exogenous arachidonate to leukotrienes (25) . However, in the presence of ionophore, soluble stimuli lead to the substantial production of leukotrienes (25) . Additionally, the conversion ofexogenous arachidonate to leukotrienes is markedly facilitated (25) . These phenomena parallel the findings in the current study and support the contention that the mesangial macrophage is the major source of glomerular LTB4. The basis of these observations may be the calcium requirement of 5-lipoxygenase (26), the initial enzyme in the leukotriene synthetic pathway.
The mechanism by which EFA deficiency diminishes glomerular LTB4 synthesis appears to differ from the mechanism by which EFA deficiency diminishes the synthesis of LTB4 from isolated leukocytes. Isolated EFA-deficient leukocytes, when stimulated with an agonist that releases endogenous fatty acids (e.g., zymosan), synthesize markedly less LTB4 than control cells ( 19, 27) . By using exogenous fatty acids, it can be demonstrated that this inhibition requires the prior metabolism of 20:3(n-9) (19, 27) . Using chemically synthesized LTA3, it has been shown that this particular metabolite of 20:3(n-9) binds to and inactivates LTA hydrolase, thus preventing the metabolism of arachidonate to LTB4 (10) . Therefore, the decrease in LTB4 formation by EFA-deficient leukocytes requires the prior release of endogenous 20:3(n-9) and presumably its metabolism to LTA3.
In the current study, however, EFA-deficient glomeruli were impaired in their ability to produce LTB4 even when provided with exogenous substrate. In contrast, EFA-deficient macrophages are able to synthesize LTB4 from exogenous arachidonate comparably to control macrophages (Lefkowith, J., unpublished observations). These findings led to the alternative hypothesis that EFA deficiency inhibited the generation of glomerular LTB4 by depleting the glomerulus of macrophages. This hypothesis was supported by the studies using irradiation to deplete glomeruli of macrophages. Glomeruli from irradiated animals were deficient in their ability to produce LTB4 from exogenous substrate but were able to produce amounts of cyclooxygenase products comparably to control.
The residual capacity of glomeruli from irradiated animals to synthesize LTB4 suggests that another cell type within the glomerulus (other than the macrophage) may be a source of this eicosanoid, since irradiation eliminates virtually all of the mesangial macrophages. A potential candidate is the smooth muscle-like mesangial cell. The mesangial cell has been shown to have the capacity to synthesize lipoxygenase products (28) , although LTB4 synthesis by these cells has not been established.
The mechanism by which EFA deficiency leads to a depletion of glomerular macrophages is unknown. However, the presence of these cells in the mesangium is clearly a specific function of (n-6) fatty acids (17) . Supplementing EFA-deficient animals with linoleate restores glomerular arachidonate, decreases glomerular 20:3(n-9), and leads to a restocking of the glomerulus with macrophages. In comparison, linolenate supplementation, which increases levels of glomerular (n-3) fatty acids but also suppresses glomerular 20:3(n-9), does not lead to a normalization in the numbers of glomerular macrophages.
The depletion of glomerular resident macrophages and consequent decrease in the ability of glomeruli to synthesize LTB4 may be central to the anti-inflammatory effect of the deficiency state. In a recent study on acute inflammation, EFA deficiency was shown to decrease numbers of resident macrophages, to diminish the generation of LTB4, and to mitigate the influx of leukocytes during the inflammatory response (29) . A causal connection between the effects of EFA deficiency on LTB4 generation and leukocyte influx was supported by experiments using the cyclooxygenase/lipoxygenase inhibitor, BW755C. This inhibitor prevented LTB4 synthesis and also decreased the influx of leukocytes during acute inflammation (29) .
In summary, the current study establishes that glomeruli have the potential to synthesize LTB4 and that the mesangial macrophage appears to be the predominant cell source of this eicosanoid. EFA deficiency impairs the generation of LTB4 by glomeruli, apparently not by inhibiting the cellular synthetic pathway, but by depleting glomeruli of the major cellular source of this eicosanoid. The effects of EFA deficiency on glomerular LTB4 synthesis may be the basis of the salutary effect of the deficiency state on renal inflammatory states.
